Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings-Reference-Cited by-同舟云学术

Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings

Published:2022-09 Issue:6 Volume:23 Page:467-476
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Yoneda Taro^ORCID,Sone Takashi,Koba Hayato^ORCID,Shibata Kazuhiko^ORCID,Suzuki Junya,Tani Mayuko,Nishitsuji Masaru,Nishi Koichi^ORCID,Kobayashi Takafumi^ORCID,Shirasaki Hiroki,Araya Tomoyuki,Kita Toshiyuki,Kase Kazumasa,Yamamura Kenta,Terada Nanao,Nishikawa Shingo,Tambo Yuichi^ORCID,Kimura Hideharu,Kasahara Kazuo

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

2. Reshma rangwala, nd julie r. brahmer.pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomized, open-label, controlled, phase III trial;Mok;Lancet,2019

4. Guidelines for diagnosis and treatment of the lun cancer/malignant pleuramesothelioma/thymic tumors 2020. The Japan lung cancer society. 2020.

5. Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer;Gandhi;N Engl J Med,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of physical activity on patients of NSCLC;Discover Oncology;2024-08-02

2. Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review);International Journal of Oncology;2024-02-13

3. Association of CirAEs and Efficacy in NSCLC Patients Treated with PD-1/PD-L1: A Meta-analysis of Cohort Studies;Combinatorial Chemistry & High Throughput Screening;2024-01-22

4. Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy;Cancers;2023-10-06

5. Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer;Cancers;2023-08-21